Background: The chromosomal locus 9p21 is a novel genetic marker for a variety of cardiovascular and cerebrovascular diseases. In a recent study, we have demonstrated an association between the single nucleotide polymorphism (SNP) rs1333040C>T on chromosome 9p21 and sporadic brain arteriovenous malformations (BAVMs). Here, we extended our analysis to an additional SNP on chromosome 9p21 (rs7865618A>G) and increased our sample size including BAVMs from two different Italian neurosurgical centers. Methods: We studied 206 patients with sporadic BAVMs and 171 unaffected controls. Genomic DNA was isolated from peripheral blood and the rs1333040C>T and rs7865618A>G polymorphisms were assessed by PCR-RFLP using the Bsm I and Msp I restriction endonucleases, respectively. For each SNP, we performed dominant, recessive, and additive genetic models. Results: The distribution of the three possible genotypes of rs1333040 (TT, TC and CC) was statistically different between cases and controls (p = 0.0008). The TT genotype was significantly associated with BAVMs both in the dominant (p = 0.013) and recessive (p = 0.012) models. The T allele was significantly associated with BAVMs in the additive model (p = 0.002). Also the distribution of the three possible genotypes of rs7865618 (GG, AG and AA) was statistically different between cases and controls (p = 0.005), and the GG genotype and G allele were significantly associated with BAVMs in the dominant (p = 0.032), recessive (p = 0.007), and additive models (p = 0.009). We also detected a significant association between BAVMs with large nidus size and the GG genotype and G allele of rs7865618 and the TT genotype of rs1333040. A deep venous drainage was instead associated with the TT genotype of the rs1333040 and the GG genotype of the rs7865618. The occurrence of bleeding was associated with the TT genotype and T allele of rs1333040, while the presence of seizures appeared associated with the GG genotype of rs7865618. Conclusions: SNPs of the 9p21 region, in addition to be genetic markers for coronary artery disease, stroke, and intracranial aneurysms, are associated with sporadic BAVMs. These results extend and strengthen the role of the 9p21 chromosomal region as a common risk factor for cerebrovascular diseases.

Keywords:
Single nucleotide polymorphism, Brain arteriovenous malformation, Chromosome 9p21
1.
McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al: A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-1491.
2.
Shen GQ, Li L, Rao S, Abdullah KG, Kan JM, Lee BS, et al: Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 2008;28:360-365.
3.
Shen GQ, Rao S, Martinelli N, Li L, Olivieri O, Corrocher R, et al: Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet 2008;53:144-150.
4.
Larson MG, Atwood LD, Benjamin EJ, Cupples LA, D'Agostino RB Sr, Fox CS, et al: Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet 2007;8(suppl 1):S5.
5.
Murabito JM, White CC, Kavousi M, Sun YV, Feitosa MF, Nambi V, et al: Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2012;5:100-112.
6.
Holdt LM, Teupser D: Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 2012;32:196-206.
7.
Bown MJ, Braund PS, Thompson J, London NJ, Samani NJ, Sayers RD: Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm. Circ Cardiovasc Genet 2008;1:39-42.
8.
Anderson CD, Biffi A, Rost NS, Cortellini L, Furie KL, Rosand J: Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke 2010;41:1123-1131.
9.
Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, et al: Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010;42:420-425.
10.
Hashikata H, Liu W, Inoue K, Mineharu Y, Yamada S, Nanayakkara S, et al: Confirmation of an association of single-nucleotide polymorphism rs1333040 on 9p21 with familial and sporadic intracranial aneurysms in Japanese patients. Stroke 2010;41:1138-1144.
11.
Sturiale CL, Gatto I, Puca A, D'Arrigo S, Giarretta I, Albanese A, et al: Association between the rs1333040 polymorphism on the chromosomal 9p21 locus and sporadic brain arteriovenous malformations. J Neurol Neurosurg Psychiatry 2013;84:1059-1062.
12.
Pasmant E, Sabbagh A, Vidaud M, Bièche I: ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011;25:444-448.
13.
Koch W, Türk S, Erl A, Hoppmann P, Pfeufer A, King L, Schömig A, Kastrati A: The chromosome 9p21 region and myocardial infarction in a European population. Atherosclerosis 2011;217:220-226.
14.
Sturiale CL, Puca A, Sebastiani P, Gatto I, Di Rocco C, Maira G, et al: Single nucleotide polymorphisms associated with brain arteriovenous malformations. Where do we stand? Brain 2013;136:665-681.
15.
Kim H, Hysi PG, Pawlikowska L, Poon A, Burchard EG, Zaroff JG, Sidney S, Ko NU, Achrol AS, Lawton MT, McCulloch CE, Kwok PY, Young WL: Common variants in interleukin-1-beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis 2009;27:176-182.
16.
Mikhak B, Weinsheimer S, Pawlikowska L, Poon A, Kwok PY, Lawton MT, Chen Y, Zaroff JG, Sidney S, McCulloch CE, Young WL, Kim H: Angiopoietin-like 4 (ANGPTL4) gene polymorphisms and risk of brain arteriovenous malformations. Cerebrovasc Dis 2011;31:338-345.
17.
Moftakhar P, Hauptman JS, Malkasian D, Martin NA: Cerebral arteriovenous malformations. Part 1: Cellular and molecular biology. Neurosurg Focus 2009;26:E10.
18.
Sturiale CL, Rigante L, Puca A, Di Lella G, Albanese A, Marchese E, Di Rocco C, Maira G, Colicchio G: Angioarchitectural features of brain arteriovenous malformations associated with seizures: a single center retrospective series. Eur J Neurol 2013;20:849-855.
19.
Cunnington MS, Santibanez Koref M, Mayosi BM, et al: Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet 2010;6:e1000899.
20.
Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, et al: Stem-cell aging modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006;443:421-426.
21.
Kim WY, Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell 2006;127:265-275.
22.
Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, et al: Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008;17:806-814.
23.
Folkersen L, Kyriakou T, Goel A, Peden J, Mälarstig A, Paulsson-Berne G, et al: Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 2009;4:e7677.
24.
Holdt LM, Beutner F, Scholz M, Gielen S, Gäbel G, Bergert H, et al: ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 2010;30:620-627.
25.
Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316:1341-1345.
26.
Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al: Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
27.
Pasmant E, Laurendeau I, Héron D, Vidaud M, Vidaud D, Bièche I: Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007;67:3963-3969.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.